Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000183510 | SCV000235970 | uncertain significance | not provided | 2018-05-21 | criteria provided, single submitter | clinical testing | The K283N variant of uncertain significance in the JUP gene has not been published as pathogenic or been reported as benign to our knowledge. This variant is observed in 3/111,686 (0.003%) European (non-Finnish) alleles in large population cohorts (Lek et al., 2016). The K283N variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. Finally, in-silico analyses, including protein predictors and evolutionary conservation, support a deleterious effect.Therefore, based on the currently available information, it is unclear whether this variant is pathogenic or rare benign. |
Labcorp Genetics |
RCV001852359 | SCV002196376 | uncertain significance | Naxos disease; Arrhythmogenic right ventricular dysplasia 12 | 2024-12-22 | criteria provided, single submitter | clinical testing | This sequence change replaces lysine, which is basic and polar, with asparagine, which is neutral and polar, at codon 283 of the JUP protein (p.Lys283Asn). This variant is present in population databases (rs794729054, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with JUP-related conditions. ClinVar contains an entry for this variant (Variation ID: 201832). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV002444742 | SCV002678518 | uncertain significance | Cardiovascular phenotype | 2023-10-23 | criteria provided, single submitter | clinical testing | The p.K283N variant (also known as c.849G>T), located in coding exon 4 of the JUP gene, results from a G to T substitution at nucleotide position 849. The lysine at codon 283 is replaced by asparagine, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV001852359 | SCV002779567 | uncertain significance | Naxos disease; Arrhythmogenic right ventricular dysplasia 12 | 2022-04-04 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV000183510 | SCV001739534 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000183510 | SCV001969864 | uncertain significance | not provided | no assertion criteria provided | clinical testing |